查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1745747

路易氏体失智症治疗的全球市场:市场规模·占有率·趋势，产业分析 (药物类别·各适应症·各流通管道·各地区)，未来预测 (2025年～2034年)

Lewy Body Dementia Treatment Market Size, Share, Trends, Industry Analysis Report: By Drug Type, Indication, Distribution Channel, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 112 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，全球路易氏体失智症治疗市场规模将达到 133.2 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

路易氏体失智症治疗市场专注于旨在控制路易氏体失智症 (LBD) 相关症状的医疗治疗和介入措施。路易氏体失智症是一种由脑内异常蛋白质沉积引起的进行性神经退化性疾病。路易氏体失智症表现为认知能力下降、运动障碍、精神症状和自主神经功能障碍，需要药物治疗和非药物治疗相结合。胆碱酯酶抑制剂、卡比多巴-左旋多巴以及剂量精准的抗精神病药物等药物疗法被广泛使用，而物理和认知復健等支持疗法在症状管理中也发挥着重要作用。

由于全球人口老化、神经退化性疾病盛行率上升以及诊断工具的进步提高了早期检测率，路易氏体失智症治疗市场正在不断增长。製药公司正在加大研发投入，临床试验也正在探索新的候选药物，以提高治疗效果。此外，政府对失智症研究的投入和资金不断增加，以及医疗成本的不断上涨，也为路易氏体失智症治疗市场创造了庞大的商机。数位医疗解决方案、远距医疗和个人化医疗等趋势正在进一步塑造市场格局。此外，预计主要公司之间的持续创新和合作将推动市场持续成长。

路易氏体失智症治疗市场：分析概述

  • 2024年，路易氏体失智症治疗市场的占有率主要由胆碱酯酶抑制剂占据。这些药物包括多奈哌齐、利凡斯的明和加兰他敏，透过抑制一种名为胆碱酯酶的酵素来发挥作用，从而增加大脑中乙酰胆碱的浓度。
  • 2024年，帕金森氏症将占据市场主导地位，因为它与路易氏体失智症的病理学重迭，这将增加对有效治疗这两种神经退化性疾病的治疗方案的需求。
  • 按地区划分，北美占据路易氏体失智症治疗市场的最大占有率，这主要归功于其庞大的患者群体、日益增强的认知度以及先进的医疗基础设施。
  • 在路易氏体失智症治疗市场中，一些关键参与者正在积极推动治疗方案的进步。这些公司包括卫材、诺华、辉瑞、葛兰素史克、罗氏、默克、强生、赛诺菲、艾伯维、阿斯特捷利康、百时美施贵宝、礼来公司、武田製药、优时比公司和大冢製药。

目录

第1章 简介

第2章 摘要整理

第3章 分析方法

第4章 全球路易氏体失智症治疗市场洞察

  • 市场概述
  • 路易氏体失智症治疗的市场动态
    • 促进因素和机会
      • 路易氏体失智症盛行率不断上升
      • 研究与临床试验的进展
    • 阻碍因素与课题
      • 缺乏有效的疾病改良疗法
  • 大环境分析
  • 路易氏体失智症治疗市场有效利用趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球路易氏体失智症治疗市场:药物类别

  • 主要的分析结果
  • 简介
  • 莫达非尼
  • 胆碱酯酶抑制剂
  • 苯二氮平类药物
  • 抗精神病药
  • 抗忧郁药
  • 卡比多巴/左旋多巴

第6章 全球路易氏体失智症治疗市场:各适应症

  • 主要的分析结果
  • 简介
  • 帕金森氏症
  • 路易氏体失智症(DLB)

第7章 全球路易氏体失智症治疗市场:各流通管道

  • 主要的分析结果
  • 简介
  • 药妆店
  • 医院药局
  • 线上药局
  • 零售药局

第8章 全球路易氏体失智症治疗市场:各地区

  • 主要的分析结果
  • 简介
    • 路易氏体失智症治疗市场分析:各地区 (2020～2034年)
  • 北美
    • 北美:药物类别(2020～2034年)
    • 北美:各适应症(2020～2034年)
    • 北美:各流通管道(2020～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:药物类别(2020～2034年)
    • 欧洲:各适应症(2020～2034年)
    • 欧洲:各流通管道(2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:药物类别(2020～2034年)
    • 亚太地区:各适应症(2020～2034年)
    • 亚太地区:各流通管道(2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:药物类别(2020～2034年)
    • 中东·非洲:各适应症(2020～2034年)
    • 中东·非洲:各流通管道(2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:药物类别(2020～2034年)
    • 南美:各适应症(2020～2034年)
    • 南美:各流通管道(2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 事业扩大·企业收购的分析
    • 事业扩大
    • 企业收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • AbbVie Inc.
  • AstraZeneca plc
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
Product Code: PM1742

The global Lewy body dementia treatment market size is expected to reach USD 13.32 billion by 2034, according to a new study by Polaris Market Research. The report "Lewy Body Dementia Treatment Market Size, Share, Trends, Industry Analysis Report: By Drug Type (Modafinil, Cholinesterase Inhibitors, Benzodiazepine, Antipsychotic Drugs, Antidepressants, and Carbidopa-Levodopa), Indication, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Lewy body dementia treatment market focuses on medical therapies and interventions aimed at managing symptoms associated with Lewy body dementia (LBD), a progressive neurodegenerative disorder caused by abnormal protein deposits in the brain. LBD presents with cognitive decline, movement impairments, psychiatric symptoms, and autonomic dysfunction, requiring a combination of pharmacological and non-pharmacological treatments. Medications such as cholinesterase inhibitors, carbidopa-levodopa, and carefully administered antipsychotics are commonly used, while supportive therapies like physical and cognitive rehabilitation play a crucial role in symptom management.

The market is experiencing growth due to an aging global population, increasing prevalence of neurodegenerative diseases, and advancements in diagnostic tools improving early detection. Pharmaceutical companies are investing in research and development, with clinical trials exploring novel drug candidates to enhance treatment efficacy. Additionally, increasing government initiatives and funding for dementia research, coupled with rising healthcare expenditure, create significant Lewy body dementia treatment market opportunities. Trends such as digital health solutions, telemedicine, and personalized medicine are further shaping the market landscape. Furthermore, ongoing innovations and collaborations among key players are expected to drive sustained growth.

Lewy Body Dementia Treatment Market Report Highlights

  • Cholinesterase inhibitors dominated the Lewy body dementia treatment market share in 2024. These medications, including donepezil, rivastigmine, and galantamine, function by inhibiting the enzyme cholinesterase, thereby increasing acetylcholine levels in the brain.
  • In 2024, the Parkinson's disease segment dominated the market due to its overlapping pathology with Lewy body dementia, driving increased demand for treatments that address both neurodegenerative conditions effectively.
  • By region, North America held the largest share in the Lewy body dementia treatment market, primarily due to a significant patient population, increased awareness, and the availability of advanced healthcare infrastructure.
  • In the Lewy body dementia treatment market, several key players are actively contributing to advancements in therapeutic options. These companies include Eisai Co., Ltd.; Novartis AG; Pfizer Inc.; GlaxoSmithKline plc; F. Hoffmann-La Roche Ltd; Merck & Co., Inc.; Johnson & Johnson; Sanofi S.A.; AbbVie Inc.; AstraZeneca plc; Bristol-Myers Squibb Company; Eli Lilly and Company; Takeda Pharmaceutical Company Limited; UCB S.A.; and Otsuka Pharmaceutical Co., Ltd.

Polaris Market Research has segmented the Lewy body dementia treatment market report on the basis of drug type, indication, distribution channel, and region:

By Drug Type Outlook (Revenue - USD Billion, 2020-2034)

  • Modafinil
  • Cholinesterase Inhibitors
  • Benzodiazepine
  • Antipsychotic Drugs
  • Antidepressants
  • Carbidopa-Levodopa

By Indication Outlook (Revenue - USD Billion, 2020-2034)

  • Parkinson's Disease
  • Dementia with Lewy Bodies (DLB)

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

  • Drug Stores
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Lewy Body Dementia Treatment Market Insights

  • 4.1. Lewy Body Dementia Treatment Market - Market Snapshot
  • 4.2. Lewy Body Dementia Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of Lewy body dementia
      • 4.2.1.2. Advancements in research and clinical trials
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of effective disease-modifying therapies
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Lewy Body Dementia Treatment Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Lewy Body Dementia Treatment Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • 5.3. Modafinil
    • 5.3.1. Global Lewy Body Dementia Treatment Market, by Modafinil, by Region, 2020-2034 (USD Billion)
  • 5.4. Cholinesterase Inhibitors
    • 5.4.1. Global Lewy Body Dementia Treatment Market, by Cholinesterase Inhibitors, by Region, 2020-2034 (USD Billion)
  • 5.5. Benzodiazepine
    • 5.5.1. Global Lewy Body Dementia Treatment Market, by Benzodiazepine, by Region, 2020-2034 (USD Billion)
  • 5.6. Antipsychotic Drugs
    • 5.6.1. Global Lewy Body Dementia Treatment Market, by Antipsychotic Drugs, by Region, 2020-2034 (USD Billion)
  • 5.7. Antidepressants
    • 5.7.1. Global Lewy Body Dementia Treatment Market, by Antidepressants, by Region, 2020-2034 (USD Billion)
  • 5.8. Carbidopa-Levodopa
    • 5.8.1. Global Lewy Body Dementia Treatment Market, by Carbidopa-Levodopa, by Region, 2020-2034 (USD Billion)

6. Global Lewy Body Dementia Treatment Market, by Indication

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • 6.3. Parkinson's Disease
    • 6.3.1. Global Lewy Body Dementia Treatment Market, by Parkinson's Disease, by Region, 2020-2034 (USD Billion)
  • 6.4. Dementia with Lewy Bodies (DLB)
    • 6.4.1. Global Lewy Body Dementia Treatment Market, by Dementia with Lewy Bodies (DLB), by Region, 2020-2034 (USD Billion)

7. Global Lewy Body Dementia Treatment Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.3. Drug Stores
    • 7.3.1. Global Lewy Body Dementia Treatment Market, by Drug Stores, by Region, 2020-2034 (USD Billion)
  • 7.4. Hospitals Pharmacies
    • 7.4.1. Global Lewy Body Dementia Treatment Market, by Hospitals Pharmacies, by Region, 2020-2034 (USD Billion)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Lewy Body Dementia Treatment Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)
  • 7.6. Retail Pharmacies
    • 7.6.1. Global Lewy Body Dementia Treatment Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)

8. Global Lewy Body Dementia Treatment Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Lewy Body Dementia Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Lewy Body Dementia Treatment Market - North America
    • 8.3.1. North America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
    • 8.3.3. North America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.4. Lewy Body Dementia Treatment Market - U.S.
      • 8.3.4.1. U.S.: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.5. Lewy Body Dementia Treatment Market - Canada
      • 8.3.5.1. Canada: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.4. Lewy Body Dementia Treatment Market - Europe
    • 8.4.1. Europe: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.4. Lewy Body Dementia Treatment Market - UK
      • 8.4.4.1. UK: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.5. Lewy Body Dementia Treatment Market - France
      • 8.4.5.1. France: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.6. Lewy Body Dementia Treatment Market - Germany
      • 8.4.6.1. Germany: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.7. Lewy Body Dementia Treatment Market - Italy
      • 8.4.7.1. Italy: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.8. Lewy Body Dementia Treatment Market - Spain
      • 8.4.8.1. Spain: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.9. Lewy Body Dementia Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.10. Lewy Body Dementia Treatment Market - Russia
      • 8.4.10.1. Russia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.11. Lewy Body Dementia Treatment Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.5. Lewy Body Dementia Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.4. Lewy Body Dementia Treatment Market - China
      • 8.5.4.1. China: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.5. Lewy Body Dementia Treatment Market - India
      • 8.5.5.1. India: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.6. Lewy Body Dementia Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.7. Lewy Body Dementia Treatment Market - Japan
      • 8.5.7.1. Japan: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.8. Lewy Body Dementia Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.9. Lewy Body Dementia Treatment Market - South Korea
      • 8.5.9.1. South Korea: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.10. Lewy Body Dementia Treatment Market - Australia
      • 8.5.10.1. Australia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.11. Lewy Body Dementia Treatment Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.6. Lewy Body Dementia Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.4. Lewy Body Dementia Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.5. Lewy Body Dementia Treatment Market - UAE
      • 8.6.5.1. UAE: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.6. Lewy Body Dementia Treatment Market - Israel
      • 8.6.6.1. Israel: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.7. Lewy Body Dementia Treatment Market - South Africa
      • 8.6.7.1. South Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.8. Lewy Body Dementia Treatment Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.7. Lewy Body Dementia Treatment Market - Latin America
    • 8.7.1. Latin America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.4. Lewy Body Dementia Treatment Market - Mexico
      • 8.7.4.1. Mexico: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.5. Lewy Body Dementia Treatment Market - Brazil
      • 8.7.5.1. Brazil: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.6. Lewy Body Dementia Treatment Market - Argentina
      • 8.7.6.1. Argentina: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.7. Lewy Body Dementia Treatment Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AstraZeneca plc
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bristol-Myers Squibb Company
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Eisai Co., Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Eli Lilly and Company
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. F. Hoffmann-La Roche Ltd
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. GlaxoSmithKline plc
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson & Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merck & Co., Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Novartis AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 2 Global Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 3 Global Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 4 North America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 5 North America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 6 North America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 7 U.S.: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 9 U.S.: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 10 Canada: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 12 Canada: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 13 Europe: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 15 Europe: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 16 UK: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 17 UK: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 18 UK: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 19 France: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 20 France: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 21 France: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 22 Germany: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 24 Germany: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 Italy: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 27 Italy: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 28 Spain: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 30 Spain: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 34 Russia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 36 Russia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 43 China: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 44 China: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 45 China: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 46 India: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 47 India: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 48 India: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 52 Japan: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 54 Japan: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 58 South Korea: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 60 South Korea: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 61 Australia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 63 Australia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 73 UAE: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 75 UAE: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 76 Israel: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 78 Israel: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 79 South Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 81 South Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 85 Latin America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 87 Latin America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 88 Mexico: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 90 Mexico: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 91 Brazil: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 93 Brazil: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 94 Argentina: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 96 Argentina: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Lewy Body Dementia Treatment Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Drug Type
  • Figure 7. Global Lewy Body Dementia Treatment Market, by Drug Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Indication
  • Figure 9. Global Lewy Body Dementia Treatment Market, by Indication, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Lewy Body Dementia Treatment Market, by Distribution Channel, 2024 & 2034 (USD Billion)